SCHEMBL25880307

SCHEMBL25880307

c1ccc(N(c2ccccc2)c2ccc3c(c2)c2cccc4c2n3c2cccc3c5ccccc5n4c32)cc1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 6/20 0.35
ALDH1A1 P00352 6/20 0.35
MAPT P10636 5/20 0.35
L3MBTL1 Q9Y468 4/20 0.35
TDP1 Q9NUW8 2/20 0.35
CYP1A2 P05177 1/20 0.35
CYP3A4 P08684 1/20 0.35
CYP2D6 P10635 1/20 0.35
CYP2C9 P11712 1/20 0.35
CYP2C19 P33261 1/20 0.35
MEN1 O00255 5/20 0.34
KMT2A Q03164 5/20 0.34
HPGD P15428 4/20 0.34
HTT P42858 3/20 0.34
POLB P06746 1/20 0.34
HSD17B10 Q99714 2/20 0.33
MAPK1 P28482 1/20 0.33
HBB P68871 1/20 0.33
ALKBH5 Q6P6C2 1/20 0.33
FTO Q9C0B1 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25880327 0.98 ALDH1A1 (0.36) KDM4EALDH1A1MAPTL3MBTL1TDP1
SCHEMBL21710579 0.95 KDM4E (0.38) KDM4EALDH1A1MAPTL3MBTL1TDP1
SCHEMBL25880318 0.94 KDM4E (0.32) KDM4EALDH1A1MAPTL3MBTL1TDP1
SCHEMBL18239160 0.92 KDM4E (0.36) KDM4EALDH1A1MAPTL3MBTL1TDP1
SCHEMBL25880312 0.91 KDM4E (0.35) KDM4EALDH1A1MAPTL3MBTL1TDP1
SCHEMBL21127163 0.90 KDM4E (0.35) KDM4EALDH1A1MAPTL3MBTL1TDP1
SCHEMBL25880331 0.89 KDM4E (0.36) KDM4EALDH1A1MAPTL3MBTL1TDP1
SCHEMBL21126780 0.89 ALDH1A1 (0.36) KDM4EALDH1A1MAPTL3MBTL1TDP1
SCHEMBL25478607 0.88 KDM4E (0.34) KDM4EALDH1A1MAPTL3MBTL1TDP1
SCHEMBL26752486 0.88 KDM4E (0.34) KDM4EALDH1A1MAPTL3MBTL1TDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230240135-A1 HETEROCYLIC COMPOUND, LIGHT-EMITTING DEVICE INCLUDING THE HETEROCYCLIC COMPOUND AND ELECTRONIC APPARATUS INCLUDING THE LIGHT-EMITTING DEVICE SAMSUNG DISPLAY CO., LTD. (KR) 2023-07-27 US disclosed
US-20230240135-A1 HETEROCYLIC COMPOUND, LIGHT-EMITTING DEVICE INCLUDING THE HETEROCYCLIC COMPOUND AND ELECTRONIC APPARATUS INCLUDING THE LIGHT-EMITTING DEVICE SAMSUNG DISPLAY CO., LTD. (KR) 2023-07-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230240135-A1 HETEROCYLIC COMPOUND, LIGHT-EMITTING DEVICE INCLUDING THE HETEROCYCLIC COMPOUND AND ELECTRONIC APPARATUS INCLUDING THE LIGHT-EMITTING DEVICE CRY1, LAGE3, NQO1 KDM4E 1533/4885ALDH1A1 22/4885MAPT 4078/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.